On-Demand Assessment from 115,000 Physicians
Everyday physicians on Sermo have discussions that shape their practices and prescribing behavior. Sermo Social Media Insights tap into these peer-peer conversations to provide valuable market intelligence not possible through other channels.
By monitoring community-wide conversations and engaging physicians through new social media tools, Sermo analysts compile detailed reports that closely examine physician perceptions and market trends.
Sermo Event™ Reports
Rapidly assess physician reaction to major events influencing the US pharmaceutical market. By engaging its community of 115,000 US physicians across 68 specialties. Sermo can project the impact of clinical trial updates, new indications, FDA findings, and more. Learn More
Sermo Category™ Reports
Mine real-world physician conversations about drugs, therapeutic areas, and disease states over any period of time. By accessing the ongoing dialogue in its MD-only community, Sermo offers a “looking glass” into unprompted, peer-to-peer conversations not available anywhere else. Learn More
| RECENT REPORTS | type |
date |
|---|---|---|
| PCP Analysis: Antidepressant Treatment Behaviors | Category | 5.4.10 |
| New Biologics: Future Landscape of Rheumatology Prescribing | Event | 4.1.10 |
| Anticoagulant Therapies: MD Social Media Conversations | Category | 3.16.10 |
| Tasigna/Gleevec/Sprycel: Evolving Trends in CML | Event | 2.22.10 |
| Cladribine/Fingolimod: Estimating the Impact of Oral MS Agents | Event | 2.22.10 |
| Diabetes: MD Social Media Conversations | Category | 2.22.10 |
| Niacin vs. Ezetimibe | Event | 2.21.10 |
Reports Give You:
- Physician transcripts
- Survey results
- Detailed Analysis
- Recommendations
- PPT Presentation
Why Sermo?
Sermo is the largest MD-only online community in the US, where over 112,000 practicing MDs discuss drugs and devices, exchange clinical insights and collaborate on difficult cases.
